1153 related articles for article (PubMed ID: 31428105)
1. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
Monteran L; Erez N
Front Immunol; 2019; 10():1835. PubMed ID: 31428105
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
3. Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.
Chen PY; Wei WF; Wu HZ; Fan LS; Wang W
Front Immunol; 2021; 12():671595. PubMed ID: 34305902
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
5. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.
De Jaeghere EA; Denys HG; De Wever O
Trends Cancer; 2019 Nov; 5(11):704-723. PubMed ID: 31735289
[TBL] [Abstract][Full Text] [Related]
6. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
Piper M; Mueller AC; Karam SD
Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies.
Mhaidly R; Mechta-Grigoriou F
Semin Immunol; 2020 Apr; 48():101417. PubMed ID: 33077325
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy.
Barrett RL; Puré E
Elife; 2020 Dec; 9():. PubMed ID: 33370234
[TBL] [Abstract][Full Text] [Related]
9. Ionizing Radiation Curtails Immunosuppressive Effects From Cancer-Associated Fibroblasts on Dendritic Cells.
Berzaghi R; Tornaas S; Lode K; Hellevik T; Martinez-Zubiaurre I
Front Immunol; 2021; 12():662594. PubMed ID: 34177901
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer.
Yamauchi M; Gibbons DL; Zong C; Fradette JJ; Bota-Rabassedas N; Kurie JM
Matrix Biol; 2020 Sep; 91-92():8-18. PubMed ID: 32442601
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma.
Xiang H; Ramil CP; Hai J; Zhang C; Wang H; Watkins AA; Afshar R; Georgiev P; Sze MA; Song XS; Curran PJ; Cheng M; Miller JR; Sun D; Loboda A; Jia Y; Moy LY; Chi A; Brandish PE
Cancer Immunol Res; 2020 Apr; 8(4):436-450. PubMed ID: 32075803
[TBL] [Abstract][Full Text] [Related]
12. Irradiated Tumor Fibroblasts Avoid Immune Recognition and Retain Immunosuppressive Functions Over Natural Killer Cells.
Yang N; Lode K; Berzaghi R; Islam A; Martinez-Zubiaurre I; Hellevik T
Front Immunol; 2020; 11():602530. PubMed ID: 33584669
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.
Soongsathitanon J; Jamjuntra P; Sumransub N; Yangngam S; De la Fuente M; Landskron G; Thuwajit P; Hermoso MA; Thuwajit C
J Immunol Res; 2021; 2021():8840066. PubMed ID: 34337083
[TBL] [Abstract][Full Text] [Related]
14. CTL Attenuation Regulated by PS1 in Cancer-Associated Fibroblast.
Zhang H; Jiang R; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F
Front Immunol; 2020; 11():999. PubMed ID: 32587587
[No Abstract] [Full Text] [Related]
15. Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response.
Xiao Y; Wang Z; Gu M; Wei P; Wang X; Li W
Clin Exp Med; 2024 Jun; 24(1):126. PubMed ID: 38864912
[TBL] [Abstract][Full Text] [Related]
16. CPT1C-positive cancer-associated fibroblast facilitates immunosuppression through promoting IL-6-induced M2-like phenotype of macrophage.
Wei R; Song J; Pan H; Liu X; Gao J
Oncoimmunology; 2024; 13(1):2352179. PubMed ID: 38746869
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between cancer-associated fibroblasts and immune cells in cancer.
An Y; Liu F; Chen Y; Yang Q
J Cell Mol Med; 2020 Jan; 24(1):13-24. PubMed ID: 31642585
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy.
Liu T; Han C; Wang S; Fang P; Ma Z; Xu L; Yin R
J Hematol Oncol; 2019 Aug; 12(1):86. PubMed ID: 31462327
[TBL] [Abstract][Full Text] [Related]
19. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential.
Milosevic V; Östman A
Ups J Med Sci; 2024; 129():. PubMed ID: 38863724
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cancer-associated fibroblasts by nanodelivery system to enhance efficacy of tumor therapy.
Ai W; Liu T; Lv C; Feng X; Wang Q
Nanomedicine (Lond); 2023 Jun; 18(15):1025-1039. PubMed ID: 37584613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
